A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Radiation Biology Bookmark and Share

Department of Radiation Biology

The Department of Radiation Biology was established to study the fundamental mechanisms of DNA replication and DNA damage repair during cell growth. Efficient DNA damage repair is important for maintaining genome integrity and preventing cancer development in normal cells, but it is also a leading cause for radiation resistance in cancer cells. The department currently has three research groups working under its chair, Binghui Shen, Ph.D to define different aspects of genome maintenance that contribute to tumor etiology and to find a solution for radiation resistance by modulating DNA damage repair pathways in cancer therapy. These groups share a common interest in radiation-induced DNA damage and repair and radiation resistance. The principal investigators and their associates will direct efforts in radiation research toward fulfilling departmental goals, and working in close collaboration with radiation oncologists and other scientists at City of Hope.
 

Binghui Shen, Ph.D. - Enzymology of DNA Replication and Repair and Mouse Models of Cancer
Dr. Shen studies enzymes and mechanisms involved in the replication and repair of DNA damage caused by radiation and other environmental insults employing genetic mouse models of cancer. 


Jeremy Stark, Ph.D. - The Regulation and Fidelity of Chromosomal Break Repair Pathways
The long-term goal of Dr. Stark’s laboratory is to understand the factors and conditions that affect the regulation and fidelity of chromosomal break repair in mammalian cells.

Yilun Liu, Ph.D. - Genome Instability and Human Diseases

Dr. Liu’s long-term agenda is to understand what aspects of genome maintenance and DNA metabolism are required for normal development and cancer prevention.
 
Yanzhong Yang, M.D., Ph.D. - Mechanisms of Gene Regulation and Genome Stability
 
The research in Dr. Yang’s laboratory focuses on studying the molecular mechanisms that regulate gene expression and genome stability, as well as their implications for human diseases.

Radiation Biology

Department of Radiation Biology

The Department of Radiation Biology was established to study the fundamental mechanisms of DNA replication and DNA damage repair during cell growth. Efficient DNA damage repair is important for maintaining genome integrity and preventing cancer development in normal cells, but it is also a leading cause for radiation resistance in cancer cells. The department currently has three research groups working under its chair, Binghui Shen, Ph.D to define different aspects of genome maintenance that contribute to tumor etiology and to find a solution for radiation resistance by modulating DNA damage repair pathways in cancer therapy. These groups share a common interest in radiation-induced DNA damage and repair and radiation resistance. The principal investigators and their associates will direct efforts in radiation research toward fulfilling departmental goals, and working in close collaboration with radiation oncologists and other scientists at City of Hope.
 

Binghui Shen, Ph.D. - Enzymology of DNA Replication and Repair and Mouse Models of Cancer
Dr. Shen studies enzymes and mechanisms involved in the replication and repair of DNA damage caused by radiation and other environmental insults employing genetic mouse models of cancer. 


Jeremy Stark, Ph.D. - The Regulation and Fidelity of Chromosomal Break Repair Pathways
The long-term goal of Dr. Stark’s laboratory is to understand the factors and conditions that affect the regulation and fidelity of chromosomal break repair in mammalian cells.

Yilun Liu, Ph.D. - Genome Instability and Human Diseases

Dr. Liu’s long-term agenda is to understand what aspects of genome maintenance and DNA metabolism are required for normal development and cancer prevention.
 
Yanzhong Yang, M.D., Ph.D. - Mechanisms of Gene Regulation and Genome Stability
 
The research in Dr. Yang’s laboratory focuses on studying the molecular mechanisms that regulate gene expression and genome stability, as well as their implications for human diseases.
Overview
Beckman Research Institute of City of Hope is responsible for fundamentally expanding the world’s understanding of how biology affects diseases such as cancer, HIV/AIDS and diabetes.
 
 
Research Departments/Divisions

City of Hope is a leader in translational research - integrating basic science, clinical research and patient care.
 

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 


NEWS & UPDATES
  • Non-Hodgkin lymphoma facts: Non-Hodgkin lymphoma is a cancer that starts in cells called lymphocytes, which are part of the body’s immune system. Lymphocytes are in the lymph nodes and other lymphoid tissues (such as the spleen and bone marrow). Non-Hodgkin lymphoma is one of the most common cancers in the U.S....
  • Few clinical cancer trials include older adults – and yet, more than 60 percent of cancer cases in the United States occur in people age 65 and older. The result is a dearth of knowledge on how to treat the very population most likely to be diagnosed with cancer. Now, the American Society of Clinical […]
  • Scientists at City of Hope and UCLA have become the first to inhibit the expression of a protein, called TWIST that promotes tumor invasion and metastasis when activated by cancer cells. As such, they’ve taken the first step in developing a potential new therapy for some of the deadliest cancers, including ovar...
  • Upon completing her final round of chemotherapy for ovarian cancer earlier this month, Maria Velazquez-McIntyre, a 51-year-old Antelope Valley resident, celebrated the milestone by giving other patients a symbol of hope – a Survivor Bell. The bell may look ordinary, but for cancer patients undergoing chemothera...
  • Many Americans understand that obesity is tied to heart disease and diabetes but, according to a new survey, too few – only 7 percent – know that obesity increases the risk of cancer. Specific biological characteristics can increase cancer risk in obese people, and multiple studies have shown correlations betwe...
  • As breast cancer survivors know, the disease’s impact lingers in ways both big and small long after treatment has ended. A new study suggests that weight gain – and a possible corresponding increase in heart disease and diabetes risk – may be part of that impact. In the first study to evaluate weight chan...
  • Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising. Clinicians, especial...
  • 720 days. That’s how long Alex Tung, 38, had to give up surfing after being diagnosed with acute myeloid leukemia. For most people, even some surfers, such a hiatus wouldn’t be a big deal, but for Tung, surfing has been everything. The Southern California resident began surfing when he was in elemen...
  • There are few among us who have not experienced loss of a friend or loved one, often without warning, or like those of us who care for people with cancer, after a lingering illness. It is a time when emotions run high and deep, and as time passes from the moment of loss, we often […]
  • For the past four years, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., has been studying how breast cancer cells spread, or metastasize, to the brain, where they become life-threatening tumors. Known as secondary brain tumors, these cancers have become increasingly common as treatment advances have ena...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. A primary symptom is a rash that arises initially in areas of the skin that are not normally exposed to sunlight....
  • There’s science camp, and then there’s “mystery” science camp. City of Hope’s new science camp for middle school students is of the especially engaging latter variety. From Monday, July 13, to Friday, July 17, rising middle-school students from across the San Gabriel Valley were presented with a “patient” with ...
  • Women diagnosed with breast cancer quickly learn their tumor’s type, meaning the characteristics that fuel its growth. That label guides the treatment of their disease, as well as their prognosis when it comes to treatment effectiveness. Sometimes, however, doctors can’t accurately predict treatment effectivene...
  • In years past, Bladder Cancer Awareness Month has been a sobering reminder of a disease with few treatment options. For patients with metastatic disease (disease that has spread from the bladder to distant organs), average survival is typically just over one year. Fortunately, things are changing. Academic inst...
  • Tina Wang was diagnosed with Stage 4 diffuse large b cell lymphoma at age 22. She first sought treatment at her local hospital, undergoing two cycles of treatment. When the treatment failed to eradicate her cancer, she came to City of Hope. Here, Wang underwent an autologous stem cell transplant and participate...